99 related articles for article (PubMed ID: 17536105)
1. Beyond detection: novel applications for PET imaging to guide cancer therapy.
Rajendran JG; Mankoff DA
J Nucl Med; 2007 Jun; 48(6):855-6. PubMed ID: 17536105
[No Abstract] [Full Text] [Related]
2. Pretreatment 18F-FAZA PET predicts success of hypoxia-directed radiochemotherapy using tirapazamine.
Beck R; Röper B; Carlsen JM; Huisman MC; Lebschi JA; Andratschke N; Picchio M; Souvatzoglou M; Machulla HJ; Piert M
J Nucl Med; 2007 Jun; 48(6):973-80. PubMed ID: 17536108
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia in head and neck cancer: studies with hypoxic positron emission tomography imaging and hypoxic cytotoxins.
Rischin D; Fisher R; Peters L; Corry J; Hicks R
Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S61-3. PubMed ID: 17848298
[No Abstract] [Full Text] [Related]
4. Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer.
Grosu AL; Souvatzoglou M; Röper B; Dobritz M; Wiedenmann N; Jacob V; Wester HJ; Reischl G; Machulla HJ; Schwaiger M; Molls M; Piert M
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):541-51. PubMed ID: 17869667
[TBL] [Abstract][Full Text] [Related]
5. Accessing radiation response using hypoxia PET imaging and oxygen sensitive electrodes: a preclinical study.
Mortensen LS; Busk M; Nordsmark M; Jakobsen S; Theil J; Overgaard J; Horsman MR
Radiother Oncol; 2011 Jun; 99(3):418-23. PubMed ID: 21723634
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia in head and neck cancer.
Isa AY; Ward TH; West CM; Slevin NJ; Homer JJ
Br J Radiol; 2006 Oct; 79(946):791-8. PubMed ID: 16854964
[TBL] [Abstract][Full Text] [Related]
7. Bioreductive drugs in cancer therapy.
Stratford IJ
BJR Suppl; 1992; 24():128-36. PubMed ID: 1341908
[No Abstract] [Full Text] [Related]
8. Hypoxia-imaging with (18)F-Misonidazole and PET: changes of kinetics during radiotherapy of head-and-neck cancer.
Eschmann SM; Paulsen F; Bedeshem C; Machulla HJ; Hehr T; Bamberg M; Bares R
Radiother Oncol; 2007 Jun; 83(3):406-10. PubMed ID: 17543402
[TBL] [Abstract][Full Text] [Related]
9. Bioreductive therapy.
Chaplin DJ
Int J Radiat Oncol Biol Phys; 1992; 22(4):685-7. PubMed ID: 1544837
[No Abstract] [Full Text] [Related]
10. Targeting hypoxia in head and neck cancer.
Peters LJ
Acta Oncol; 2001; 40(8):937-40. PubMed ID: 11845958
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin as a radiosensitizer in the treatment of locally advanced head and neck cancer.
Altundag O; Altundag K; Morandi P; Hanrahan E
Oral Oncol; 2005 Apr; 41(4):435. PubMed ID: 15792617
[No Abstract] [Full Text] [Related]
12. The response of a transplantable tumor to fractionated irradiation. 1. X rays and the hypoxic cell radiosensitizer Ro-07-0582.
Denekamp J; Harris SR
Radiat Res; 1976 Apr; 66(1):66-75. PubMed ID: 1257411
[No Abstract] [Full Text] [Related]
13. Identifying and targeting hypoxia in head and neck cancer: a brief overview of current approaches.
Le QT
Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S56-8. PubMed ID: 17848296
[No Abstract] [Full Text] [Related]
14. More lessons learned from the suffocation of hypoxia.
Ang KK
J Clin Oncol; 2010 Jun; 28(18):2941-3. PubMed ID: 20479396
[No Abstract] [Full Text] [Related]
15. Tests of two electron-affinic radiosensitizers in vivo using regrowth of an experimental carcinoma.
Denekamp J; Harris SR
Radiat Res; 1975 Feb; 61(2):191-203. PubMed ID: 1110975
[No Abstract] [Full Text] [Related]
16. The response of a transplantable tumor to fractionated irradiation. III. Fast neutrons plus the radiosensitizer Ro-07-0582.
Denekamp J; Morris C; Field SB
Radiat Res; 1977 May; 70(2):425-32. PubMed ID: 860014
[No Abstract] [Full Text] [Related]
17. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
Vordermark D; Brown JM
Strahlenther Onkol; 2003 Dec; 179(12):801-11. PubMed ID: 14652668
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of [18F]FETNIM: a potential marker for PET.
Grönroos T; Eskola O; Lehtiö K; Minn H; Marjamäki P; Bergman J; Haaparanta M; Forsback S; Solin O
J Nucl Med; 2001 Sep; 42(9):1397-404. PubMed ID: 11535732
[TBL] [Abstract][Full Text] [Related]
19. Combining radiotherapy with systemic therapies.
Vokes EE
Clin Adv Hematol Oncol; 2008 Mar; 6(3):167-9. PubMed ID: 18391914
[No Abstract] [Full Text] [Related]
20. A model of reoxygenation dynamics of head-and-neck tumors based on serial 18F-fluoromisonidazole positron emission tomography investigations.
Thorwarth D; Eschmann SM; Paulsen F; Alber M
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):515-21. PubMed ID: 17398015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
